Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype
- PMID: 12810862
- DOI: 10.1099/vir.0.19074-0
Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype
Abstract
Several host proteins have been shown to play key roles in the life-cycle of vesicular stomatitis virus (VSV). We have identified an additional host protein, cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase activity, as one of the cellular factors required for VSV replication. Inhibition of the enzymatic activity of cellular CypA by cyclosporin A (CsA) or SDZ-211-811 resulted in a drastic inhibition of gene expression by VSV New Jersey (VSV-NJ) serotype, while these drugs had a significantly reduced effect on the genome expression of VSV Indiana (VSV-IND) serotype. Overexpression of a catalytically inactive mutant of CypA resulted in the reduction of VSV-NJ replication, suggesting a requirement for functional CypA for VSV-NJ infection. It was also shown that CypA interacted with the nucleocapsid (N) protein of VSV-NJ and VSV-IND in infected cells and was incorporated into the released virions of both serotypes. VSV-NJ utilized CypA for post-entry intracellular primary transcription, since inhibition of CypA with CsA reduced primary transcription of VSV-NJ by 85-90 %, whereas reduction for VSV-IND was only 10 %. Thus, it seems that cellular CypA binds to the N protein of both serotypes of VSV. However, it performs an obligatory function on the N protein activity of VSV-NJ, while its requirement is significantly less critical for VSV-IND N protein function. The different requirements for CypA by two serologically different viruses belonging to the same family has highlighted the utilization of specific host factors during their evolutionary lineages.
Similar articles
-
Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids.Virology. 1994 Feb 15;199(1):11-9. doi: 10.1006/viro.1994.1093. Virology. 1994. PMID: 8116233
-
Utilization of homotypic and heterotypic proteins of vesicular stomatitis virus by defective interfering particle genomes for RNA replication and virion assembly: implications for the mechanism of homologous viral interference.J Virol. 2005 Aug;79(15):9588-96. doi: 10.1128/JVI.79.15.9588-9596.2005. J Virol. 2005. PMID: 16014921 Free PMC article.
-
Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.Virus Res. 1985 Sep;3(2):129-40. doi: 10.1016/0168-1702(85)90003-6. Virus Res. 1985. PMID: 2414943
-
Insights into the roles of cyclophilin A during influenza virus infection.Viruses. 2013 Jan 15;5(1):182-91. doi: 10.3390/v5010182. Viruses. 2013. PMID: 23322171 Free PMC article. Review.
-
Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.Curr Issues Mol Biol. 2017;21:1-20. doi: 10.21775/cimb.021.001. Epub 2016 Mar 31. Curr Issues Mol Biol. 2017. PMID: 27033630 Review.
Cited by
-
Phospholipid scramblase 1 potentiates the antiviral activity of interferon.J Virol. 2004 Sep;78(17):8983-93. doi: 10.1128/JVI.78.17.8983-8993.2004. J Virol. 2004. PMID: 15308695 Free PMC article.
-
Inhibition of Cyclophilin A on the replication of red spotted grouper nervous necrosis virus associates with multiple pro-inflammatory factors.Fish Shellfish Immunol. 2019 Sep;92:172-180. doi: 10.1016/j.fsi.2019.05.064. Epub 2019 Jun 5. Fish Shellfish Immunol. 2019. PMID: 31176008 Free PMC article.
-
Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles.Virology. 2012 Jan 20;422(2):205-13. doi: 10.1016/j.virol.2011.10.029. Epub 2011 Nov 14. Virology. 2012. PMID: 22088217 Free PMC article.
-
Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?Front Med (Lausanne). 2021 Sep 6;8:663708. doi: 10.3389/fmed.2021.663708. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34552938 Free PMC article. Review.
-
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.J Virol. 2005 Jun;79(11):6577-87. doi: 10.1128/JVI.79.11.6577-6587.2005. J Virol. 2005. PMID: 15890896 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources